LYRNX Performance — Lyrical International Value Equity Fund, Investor Class
Data updated: 2026-10-15
LYRNX returned +9.95% year to date and +22.35% over one year to May 2026. Annualised returns are +16.54% over 3 years and +6.80% over 5 years. The fund trailed its International Multi-Cap Value category average: $100 invested three years ago grew to $158, against $174 for the category, and to $122 over one year, against $128. Volatility over the past three years was 15.64% a year. In the 12 months to May 2026 the fund took in a net $32.3M, and assets reached $38.39M.
LYRNX Growth of $100
What $100 invested in Lyrical International Value Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the International Multi-Cap Value category average over the same months.
| Period | LYRNX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $122 | $128 |
| 3 years (Jun 2023 – May 2026) | $158 | $174 |
| 5 years (Jun 2021 – May 2026) | $139 | $160 |
| Since data start (Mar 2020 – May 2026) | $218 | $210 |
LYRNX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +9.95% |
| 1 year | +22.35% |
| 3 years (annualised) | +16.54% |
| 5 years (annualised) | +6.80% |
LYRNX Annual Returns
Calendar-year total returns of Lyrical International Value Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +9.95% |
| 2025 | +35.41% |
| 2024 | −2.51% |
| 2023 | +12.96% |
| 2022 | −12.94% |
| 2021 | +15.37% |
| 2020 (Mar–Dec) | +32.58% |
LYRNX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.6% | +3.4% | −10.3% | +8.8% | +5.0% | — | — | — | — | — | — | — |
| 2025 | +3.2% | +4.2% | +2.2% | +5.5% | +4.9% | +5.4% | −2.0% | +3.1% | +1.2% | +0.5% | +0.4% | +2.4% |
| 2024 | +0.7% | −0.1% | +3.0% | −3.9% | +6.8% | −6.1% | +5.9% | +1.2% | −0.2% | −4.8% | +0.3% | −4.4% |
| 2023 | +8.6% | −3.5% | +0.3% | +2.2% | −3.6% | +6.0% | +3.0% | −5.0% | −5.3% | −3.8% | +6.9% | +8.0% |
| 2022 | −2.9% | −3.2% | −1.0% | −8.1% | +4.4% | −10.7% | +7.1% | −4.6% | −10.9% | +8.5% | +13.1% | −2.3% |
| 2021 | −1.0% | +8.4% | +4.6% | +2.5% | +3.1% | −2.4% | −0.6% | +1.6% | −0.9% | +1.4% | −5.6% | +4.2% |
| 2020 | — | — | 0.0% | +0.1% | 0.0% | +3.1% | +2.3% | +5.5% | −2.9% | −1.7% | +19.3% | +4.5% |
LYRNX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 15.64%
- 3-year Sharpe ratio: 0.77 (vs 4.5% risk-free rate)
- Best month: +8.81% (Apr 2026)
- Worst month: −10.26% (Mar 2026)
LYRNX Fund Flows
Monthly money in and out of Lyrical International Value Equity Fund, from SEC Form N-PORT.
- 12-month net flow: $32.3M
- 12-month gross sales (incl. reinvestments): $32.6M
- Sales ÷ redemptions: 84.52×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $104K | $0 | $104K |
| Apr 2026 | $3K | $0 | $3K |
| Mar 2026 | $17.0M | $13K | $17.0M |
| Feb 2026 | $7.5M | $665 | $7.5M |
| Jan 2026 | $50K | $260K | −$210K |
| Dec 2025 | $623K | $52K | $571K |
| Nov 2025 | $60K | $2K | $58K |
| Oct 2025 | $100K | $5K | $95K |
| Sep 2025 | $0 | $27K | −$27K |
| Aug 2025 | $7.0M | $0 | $7.0M |
| Jul 2025 | $168K | $27K | $141K |
| Jun 2025 | $0 | $125 | −$125 |
LYRNX Assets Under Management
Net assets of Lyrical International Value Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-08-31 | $38.39M |
| 2026-05-31 | $38.00M |
| 2026-02-28 | $18.50M |
| 2025-11-30 | $9.53M |
| 2025-08-31 | $9.65M |
| 2025-05-31 | $2.44M |
| 2025-02-28 | $12.63M |
| 2024-11-30 | $12.68M |
| 2024-08-31 | $13.30M |
| 2024-05-31 | $13.25M |
| 2024-02-29 | $12.46M |
| 2023-11-30 | $11.57M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.